Tarsus Pharmaceuticals, Inc. (TARS) Financials

TARS Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 266.2 million 69.2 million
2023-09-30 268.3 million 54.7 million
2023-06-30 188.9 million 41.2 million
2023-03-31 211.2 million 37.8 million

TARS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -35.3 million 5.5 million
2023-09-30 -36.7 million 5.3 million
2023-06-30 -24.6 million 5.2 million
2023-03-31 -22.3 million 3.9 million

TARS Net Income

No data available :(

TARS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 227.4 million - 398000
2023-09-30 246.9 million - 423000
2023-06-30 178.2 million - 431000
2023-03-31 201.2 million - 703000

TARS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 31.9 million
2023-09-30 30.6 million
2023-06-30 26.8 million
2023-03-31 26.7 million

TARS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 4.0 million 13.3 million 65.7 million 22.7 million
2023-09-30 4.4 million 12.1 million 30.3 million -
2023-06-30 787000 12.5 million 20.3 million -
2023-03-31 340000 12.4 million 15.1 million -

TARS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 13.1 million 1.2 million
2023-09-30 1.9 million 377000
2023-06-30 15.3 million 316000
2023-03-31 2.5 million 255000

TARS

Price: $32.12

52 week price:
11.33
40.40

Earnings Per Share: -4.62 USD

P/E Ratio: -7.43

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 37491

Market Capitalization: 1.3 billion

Links: